Back to search

Article

Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19

2021-05-12

Abstract excerpt

The introduction of vaccines has inspired new hope in the battle against SARS-CoV-2. However, the emergence of viral variants, in the absence of potent antivirals, has left the world struggling with the uncertain nature of this disease. Antibodies currently represent the strongest correlate of immunity against COVID-19, thus we profiled the earliest humoral signatures in a large cohort of severe and asymptomatic C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2eea6e56-f1d1-567b-9f14-400fb593523d
DOI
10.1101/2021.05.11.443609
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19DOI 10.1101/2021.05.11.443609
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19Semantic proximity
Differential antibody dynamics to SARS-CoV-2 infection and vaccinationSemantic proximity
Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and AgeSemantic proximity
Pre-Existing Cellular Immunity to SARS-CoV-2 Through an Immunodominant EpitopeSemantic proximity
No substantial pre-existing B cell immunity against SARS-CoV-2 in healthy adultsSemantic proximity
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of diseaseSemantic proximity
Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19Semantic proximity
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.Semantic proximity
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunitySemantic proximity
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case reportSemantic proximity
Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with ageSemantic proximity
SARS-CoV-2: The Interplay Between Evolution and Host Immunity.Semantic proximity
Select a neighboring publication to make it the new centre.